Atlas Trials

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Clinical trial NCT04703842 · RECRUITING

Trial details

NCT number
NCT04703842
Sponsor
Sardocor Corp.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Congestive Heart FailureHeart Failure, SystolicHeart FailureHFrEF - Heart Failure With Reduced Ejection Fraction
Start date
2021-09-23
Primary completion
2025-12-31
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.